SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lavigne Christophe

(Last)

(First)

(Middle)

13785 RESEARCH BLVD., SUITE 200

(Street)

AUSTIN

78750

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/08/2013

3. Issuer Name and Ticker or Trading Symbol
LDR HOLDING CORP [ P139 ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO and Chairman

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	116,981	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option (right to buy)	04/01/2009⁽¹⁾	04/01/2014	Common Stock	11,111	$1.9305	D
Incentive Stock Option (right to buy)	01/01/2012⁽²⁾	11/19/2015	Common Stock	20,056	$3.4155	D
Incentive Stock Option (right to buy)	07/10/2013⁽³⁾	07/10/2022	Common Stock	10,737	$6.534	D
Medical Class A Stock	⁽⁴⁾	⁽⁴⁾	Common Stock⁽⁴⁾	1,161,335	⁽⁴⁾	D
Non-Qualified Stock Option (right to buy)	07/10/2013⁽³⁾	07/10/2022	Common Stock	24,315	$6.534	D

Explanation of Responses:

1. The option becomes exercisable for 100% of the shares granted immediately on April 1, 2009.

2. The option becomes exercisable for 25% of the shares granted one year from the vesting commencement date of January 1, 2011, then in thirty-six equal monthly installments thereafter.

3. ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of July 10, 2012, then in thirty-six equal monthly installments thereafter.

4. The Medical Class A Stock, which is capital stock of the Issuer's majority-owned subsidiary LDR Medical S.A.S., is convertible into the Issuer's Common Stock on a 1 for 5.80087 basis and has no expiration date.

Remarks:

Exhibit 24.1 - Confirming Statement

	By: Denise Cruz For: Christophe Lavigne	10/08/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.